Mingjun Xiang - Search Results

Year	Number of Results
2008	1
2009	1
2012	1
2014	1
2017	2
2018	1
2019	1
2021	1
2022	2
2023	1
2024	0

1

Xiang M, Namani A, Wu S, Wang X. Xiang M, et al. J Cancer Res Clin Oncol. 2014 Aug;140(8):1251-9. doi: 10.1007/s00432-014-1627-1. Epub 2014 Mar 6. J Cancer Res Clin Oncol. 2014. PMID: 24599821 Review.

2

ILP-2: A New Bane and Therapeutic Target for Human Cancers.

Zhang Z, Xiang S, Cui R, Peng H, Mridul R, Xiang M. Zhang Z, et al. Among authors: xiang m. Front Oncol. 2022 Jun 23;12:922596. doi: 10.3389/fonc.2022.922596. eCollection 2022. Front Oncol. 2022. PMID: 35814477 Free PMC article. Review.

3

Magnesium deficiency in liver cirrhosis: a retrospective study.

Peng X, Xiang R, Li X, Tian H, Li C, Peng Z, Xiang M. Peng X, et al. Among authors: xiang m. Scand J Gastroenterol. 2021 Apr;56(4):463-468. doi: 10.1080/00365521.2021.1888154. Epub 2021 Mar 1. Scand J Gastroenterol. 2021. PMID: 33646920

4

Proteomic analysis of inhibitor of apoptosis protein‑like protein‑2 on breast cancer cell proliferation.

Xiang S, Zhu L, Zhang Z, Wang S, Cui R, Xiang M. Xiang S, et al. Among authors: xiang m. Mol Med Rep. 2022 Mar;25(3):89. doi: 10.3892/mmr.2022.12605. Epub 2022 Jan 18. Mol Med Rep. 2022. PMID: 35039877 Free PMC article.

5

Serotonin receptors 2A and 1A modulate anxiety-like behavior in post-traumatic stress disordered mice.

Xiang M, Jiang Y, Hu Z, Yang Y, Du X, Botchway BO, Fang M. Xiang M, et al. Am J Transl Res. 2019 Apr 15;11(4):2288-2303. eCollection 2019. Am J Transl Res. 2019. PMID: 31105836 Free PMC article.

6

Presence of MET exon 14 skipping and fusion as mechanism of osimertinb resistance in a lung adenocarcinoma with an EGFR exon 19 deletion that responds to combination of capmatinib and osimertinb: A case report.

Xiang S, Zeng L, Xiang M, Zhang Y. Xiang S, et al. Among authors: xiang m. Heliyon. 2023 Nov 18;9(11):e22515. doi: 10.1016/j.heliyon.2023.e22515. eCollection 2023 Nov. Heliyon. 2023. PMID: 38074875 Free PMC article.

7

Inhibitor of apoptosis protein‑like protein‑2: A novel growth accelerator for breast cancer cells.

Zhu L, Zhou W, Zhu X, Xiang S, Wang S, Peng Y, Lu B, Tang P, Chen Q, Wu M, Peng X, Chen Z, Sun Z, Yang K, Xiang M, Yu D. Zhu L, et al. Among authors: xiang m. Oncol Rep. 2018 Oct;40(4):2047-2055. doi: 10.3892/or.2018.6626. Epub 2018 Aug 3. Oncol Rep. 2018. PMID: 30106449 Free PMC article.

8

Inhibitor of apoptosis protein-like protein-2 as a novel serological biomarker for breast cancer.

Xiang M, Zhou W, Gao D, Fang X, Liu Q. Xiang M, et al. Int J Mol Sci. 2012 Dec 7;13(12):16737-50. doi: 10.3390/ijms131216737. Int J Mol Sci. 2012. PMID: 23222679 Free PMC article.

9

Correlation of expression of human arrest-defective-1 (hARD1) protein with breast cancer.

Yu M, Ma M, Huang C, Yang H, Lai J, Yan S, Li L, Xiang M, Tan D. Yu M, et al. Among authors: xiang m. Cancer Invest. 2009 Dec;27(10):978-83. doi: 10.3109/07357900902769723. Cancer Invest. 2009. PMID: 19909012

10

The post-therapeutic effect of rapamycin in mild traumatic brain-injured rats ensuing in the upregulation of autophagy and mitophagy.

Wang C, Hu Z, Zou Y, Xiang M, Jiang Y, Botchway BOA, Huo X, Du X, Fang M. Wang C, et al. Among authors: xiang m. Cell Biol Int. 2017 Sep;41(9):1039-1047. doi: 10.1002/cbin.10820. Epub 2017 Jul 31. Cell Biol Int. 2017. PMID: 28685977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year